These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 10613986

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Monophosphoryl lipid A attenuates myocardial stunning in dogs: role of ATP-sensitive potassium channels.
    Elliott GT, Mei DA, Gross GJ.
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):49-56. PubMed ID: 9676720
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of inducible nitric oxide synthase in pharmacological "preconditioning" with monophosphoryl lipid A.
    Zhao L, Weber PA, Smith JR, Comerford ML, Elliott GT.
    J Mol Cell Cardiol; 1997 Jun; 29(6):1567-76. PubMed ID: 9220342
    [Abstract] [Full Text] [Related]

  • 8. Pharmacologic enhancement of tolerance to ischemic cardiac stress using monophosphoryl lipid A. A comparison with antecedent ischemia.
    Zhao L, Elliott GT.
    Ann N Y Acad Sci; 1999 Jun 30; 874():222-35. PubMed ID: 10415534
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1.
    Kloner RA, Jennings RB.
    Circulation; 2001 Dec 11; 104(24):2981-9. PubMed ID: 11739316
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2.
    Kloner RA, Jennings RB.
    Circulation; 2001 Dec 18; 104(25):3158-67. PubMed ID: 11748117
    [Abstract] [Full Text] [Related]

  • 17. Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide.
    Tosaki A, Maulik N, Elliott GT, Blasig IE, Engelman RM, Das DK.
    J Pharmacol Exp Ther; 1998 Jun 18; 285(3):1274-9. PubMed ID: 9618433
    [Abstract] [Full Text] [Related]

  • 18. [-Myocardial protection by preconditioning. Experimental and clinical significance-].
    Strasser R, Vogt A, Schaper W.
    Z Kardiol; 1996 Feb 18; 85(2):79-89. PubMed ID: 8650986
    [Abstract] [Full Text] [Related]

  • 19. A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Efficacy, time course, and role of KATP channels.
    Yao Z, Gross GJ.
    Circulation; 1994 Mar 18; 89(3):1229-36. PubMed ID: 8124811
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.